chr22-42387068-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145912.8(NFAM1):c.674G>A(p.Arg225His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000342 in 1,580,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145912.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFAM1 | NM_145912.8 | c.674G>A | p.Arg225His | missense_variant | 5/6 | ENST00000329021.10 | NP_666017.1 | |
NFAM1 | NM_001371362.1 | c.518G>A | p.Arg173His | missense_variant | 7/8 | NP_001358291.1 | ||
NFAM1 | NM_001318323.3 | c.561G>A | p.Ala187Ala | synonymous_variant | 4/5 | NP_001305252.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000623 AC: 14AN: 224766Hom.: 0 AF XY: 0.0000733 AC XY: 9AN XY: 122864
GnomAD4 exome AF: 0.0000343 AC: 49AN: 1428232Hom.: 0 Cov.: 27 AF XY: 0.0000436 AC XY: 31AN XY: 710820
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 11, 2024 | The c.674G>A (p.R225H) alteration is located in exon 5 (coding exon 5) of the NFAM1 gene. This alteration results from a G to A substitution at nucleotide position 674, causing the arginine (R) at amino acid position 225 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at